China's OTC market capacity is at the forefront of the world
With the continuous improvement of living standards, people are paying more and more attention to health, and the demand for OTC drugs and health products is also increasing. China's OTC industry h...
With the continuous improvement of living standards, people are paying more and more attention to health, and the demand for OTC drugs and health products is also increasing. China's OTC industry has developed rapidly. Since 2000, China's OTC market has expanded rapidly. In 2011, the market scale was close to 140 billion yuan, accounting for 15% to 20% of China's pharmaceutical sales. The OTC market capacity has leapt to the forefront of the world.
The data shows that there are nearly 5,000 OTC drugs in China and more than 3,000 OTC manufacturers. OTC varieties have wider availability and popularity. It is estimated that by 2014, China's OTC market will exceed 180 billion yuan, and by 2020 China may become the world's largest OTC market.
"At present, China's medical resources are unevenly distributed, medical resources are excessively concentrated in large cities and large hospitals, and community medical resources are insufficient. Self-medication can be an effective supplement to clinical treatment." Chairman of the World Self-medication Industry Alliance, Yuhong Pharmaceutical Group Guo Zhenyu, chairman of the company, believes that although China's OTC market is growing at a faster rate, its huge market potential has not been fully released.
According to industry analysts, on the one hand, the awareness of self-medication among ordinary people in China is not yet popular. Whether it is a small illness or a chronic disease, most people will choose to go to hospital for treatment, instead of going to the pharmacy to buy medicine for self-medication; on the other hand, the state’s Positioning has also affected the overall development of the OTC market to some extent. Although China has implemented drug classification management, OTC registration, conversion, labeling, manual management and price management methods do not fully reflect the characteristics of OTC, and are strictly limited as prescription drugs. Taking the approval of new drugs as an example, OTC does not have a separate entry threshold. Like prescription drugs, after the listing, it undergoes rigorous clinical trials, complicated registration procedures and long-term approval procedures, which also affects the production of OTC. Enthusiasm.
In this regard, experts suggest that China should highlight the characteristics of OTC itself in the OTC market management, simplify the OTC registration and conversion process, encourage OTC product innovation, and actively foster and support the creation of the OTC brand. At the same time, in the formulation of medical macro development plans and medical reform policies, we must pay more attention to and support active and responsible self-medication. Bai Huiliang pointed out that since OTC is mostly purchased by consumers, the packaging should clearly indicate the description of the disease that the patient can easily understand. The manual should also take into account the understanding of the consumer while including the unified template content specified by the state, thereby helping the public. Popularize the knowledge of the rational use of OTC and form a sense of self-medication.